Imeglimin exerts favorable effects on pancreatic β-cells by improving morphology in mitochondria and increasing the number of insulin granules

HIGHLIGHTS

• who: Junpei Sanada from the Department have published the research work: Imeglimin exerts favorable effects on pancreatic u03b2-cells by improving morphology in mitochondria and increasing the number of insulin granules, in the Journal: Scientific Reports Scientific Reports
• what: The authors examined the effect of imeglimin, a new anti-diabetic drug, on pancreatic u03b2-cells using type 2 diabetic mice. The study was approved by the animal use committee of Kawasaki Medical School (NO.19-103) and conducted in compliance with the animal use guidelines of Kawasaki Medical School.
• how: The experiment was . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.